E Fund Management
CABA icon

E Fund Management’s Cabaletta Bio CABA Stock Holding History

E Fund Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Buy
+20,601
New +$67.8K ﹤0.01% 483
2024
Q4 		– Sell
-280,133
Closed -$1.32M – 401
2024
Q3 		$1.32M Sell
280,133
-6,291
-2% -$36.4K 0.07% 119
2024
Q2 		$2.14M Buy
286,424
+269,675
+1,610% +$3.31M 0.12% 81
2024
Q1 		$286K Buy
16,749
+5,510
+49% +$118K 0.02% 282
2023
Q4 		$255K Buy
+11,239
New +$189K 0.02% 253

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

E Fund Management's CABA Position: Q2 2026 in Review

E Fund Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 20,601 shares worth $64.1K. The stake represents ﹤0.01% of the portfolio and ranks #483 among its holdings. This is a return to the name: E Fund Management previously reported a position in CABA as recently as Q3 2024.

E Fund Management first reported a position in CABA in Q4 2023 and has held it in 5 quarters since. The position peaked at $2.14M in Q2 2024. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • E Fund Management held 20,601 shares of Cabaletta Bio worth $64.1K as of Q2 2026.
  • Cabaletta Bio was a new E Fund Management position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #483 holding.
  • E Fund Management first reported a position in Cabaletta Bio in Q4 2023 and has held it in 5 quarters since.
  • E Fund Management's Cabaletta Bio position peaked at $2.14M in Q2 2024.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.